Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2023-11-07 Transaction in Own Shar…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 44 - 2023
Transaction in Own Shares Classification · 1% confidence The document contains detailed tables listing transactions involving the issuer 'IPSEN' and various market codes (AQEU, CEUX, TQEX, XPAR) with dates, volumes, and prices. The second table explicitly details 'Nom du PSI' (Participant/Reporting Party) and 'Objectif du rachat' (Purpose of the repurchase), indicating transactions related to share ownership or trading activity. This structure strongly suggests a report detailing personal share transactions by directors or executives, or transactions in own shares. Given the context of reporting individual transactions by parties involved with the company, the most fitting category is Director's Dealing (DIRS) or Transaction in Own Shares (POS). Since the data appears to be a regulatory filing detailing transactions (often required for insider trading or share buybacks), and the structure resembles mandatory disclosure tables for insider transactions (often required by European regulators like AMF, which uses French headers), 'DIRS' (Director's Dealing) is a strong candidate if these are insider trades, or 'POS' (Transaction in Own Shares) if it's the company buying back stock. The presence of 'Nom du PSI' (BNP Paribas SA) suggests these might be transactions executed by a third party on behalf of the company or insiders. However, the first table explicitly lists 'Volume total journalier' and 'Prix pondéré moyen journalier d'acquisition des actions', which is characteristic of mandatory disclosures regarding insider transactions or share repurchase programs. Since the data is granular transaction reporting rather than a high-level announcement, and it details specific trades, 'DIRS' (Director's Dealing) or 'POS' (Transaction in Own Shares) are the best fits. Given the format is a detailed log of transactions, DIRS is often used for insider reporting, while POS is for buybacks. Without explicit confirmation of *who* is trading (insider vs. company), DIRS is a common classification for detailed transaction logs involving individuals/related parties. However, the second table's column 'Objectif du rachat' (Purpose of the repurchase) leans towards POS if the transactions are company-initiated buybacks. Since the data is a detailed report of transactions, and not just a brief announcement, it is not RPA or RNS. Given the ambiguity between DIRS and POS, and the presence of transaction details, I will classify it as DIRS as it covers personal dealings which are frequently reported in this tabular format.
2023-11-07 English
Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references French regulatory articles (Code de commerce and AMF General Regulation) and provides a monthly update (as of October 31, 2023) detailing the total number of shares and the gross/net voting rights. This structure is characteristic of a mandatory regulatory disclosure concerning the capital structure and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it reports on the composition of the capital, or potentially a general 'Regulatory Filing' (RNS). Given the specific focus on the total number of shares and voting rights, SHA is the most precise fit, as it details the capital structure components.
2023-11-06 French
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Monthly information relative to the total number of voting rights and shares composing the share capital" and provides a table detailing the total number of shares and voting rights as of October 31, 2023. This type of regular disclosure regarding the capital structure and voting rights, often mandated by local financial regulators (like the AMF in France, mentioned in the text), does not fit neatly into the primary financial report categories (10-K, IR, ER). It is a specific regulatory disclosure concerning share capital and voting power. While it relates to share capital, it is not a general financing announcement (CAP) or a major shareholding notification (MRQ, which usually reports changes crossing thresholds by external parties). Given the specific nature of monthly voting rights disclosure, it is best classified under the general regulatory filing category, RNS, as it is a mandatory, periodic regulatory update that doesn't match the other specific definitions.
2023-11-06 English
IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2023
Transaction in Own Shares Classification · 1% confidence The document consists of detailed tables listing transactions involving the issuer's shares ('Name of issuer: IPSEN'), including the date of transaction, volume, price, and market codes. The tables explicitly detail 'Purpose of buy back' in the second table, although the column is mostly empty, the structure strongly suggests reporting of share transactions. This pattern matches the definition of a report detailing the company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category (POS). The presence of specific transaction dates (e.g., 23/10/2023) and detailed volume/price data confirms this is a transactional report, not just an announcement of one.
2023-10-31 English
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 43 - 2023
Transaction in Own Shares Classification · 1% confidence The document text consists of detailed tables reporting daily transactions of shares by an issuer ('IPSEN'). The tables list the date of transaction, volume, price, and market. This structure is characteristic of mandatory regulatory filings disclosing insider transactions or transactions in own shares by directors/executives. Reviewing the definitions, 'Director's Dealing' (DIRS) covers personal share transactions by directors, and 'Transaction in Own Shares' (POS) covers the company buying back/selling its own shares. Since the document details multiple transactions across several days (23/10/2023, 24/10/2023, etc.) involving specific volumes and prices, it strongly suggests a disclosure of share transactions. Given the context of regulatory filings, this format is most closely aligned with disclosures required for insider trading or share repurchase programs. The presence of 'Objectif du rachat' (Buyback objective) in the second table strongly points towards the company executing transactions in its own shares (share repurchase program). Therefore, the most appropriate classification is Transaction in Own Shares (POS).
2023-10-31 French
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance
Earnings Release Classification · 1% confidence The document is titled with a headline announcing 'solid sales growth in the first nine months of 2023' and presents detailed financial tables comparing Year-to-Date (YTD) 2023 sales (€2,309.1m) against YTD 2022, as well as Q3 2023 sales against Q3 2022. It confirms full-year guidance and discusses pipeline progress based on these nine-month results. This structure—presenting detailed, period-specific financial performance figures (YTD and Quarterly) and confirming guidance—is characteristic of an Interim/Quarterly Report (IR). It is too detailed to be just an Earnings Release (ER) and covers a period shorter than a full year, ruling out a 10-K. The document is a comprehensive financial update for a period shorter than a year (nine months ending September 30, 2023). 9M 2023
2023-10-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.